SXL
IBB icon

Summit X LLC’s iShares Biotechnology ETF IBB Stock Holding History

Summit X LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-197
Closed -$542 – 322
2020
Q3 		$542 Buy
+197
New +$26.7K 0.01% 304
2018
Q4 		– Sell
-21,944
Closed -$2.67M – 219
2018
Q3 		$2.67M Buy
21,944
+8,680
+65% +$1.02M 1.31% 18
2018
Q2 		$1.45M Sell
13,264
-1,518
-10% -$162K 0.81% 31
2018
Q1 		$1.57M Buy
14,782
+12,736
+622% +$1.41M 0.94% 28
2017
Q4 		$218K Sell
2,046
-25,686
-93% -$2.75M 0.14% 166
2017
Q3 		$3.08M Buy
27,732
+972
+4% +$104K 2.04% 10
2017
Q2 		$2.76M Buy
+26,760
New +$2.64M 1.97% 9

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Summit X LLC's IBB Position: Q4 2020 in Review

Summit X LLC sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 197 shares — an estimated $542 sold.

Summit X LLC first reported a position in IBB in Q2 2017 and held it in 7 quarters. The position peaked at $3.08M in Q3 2017. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

  • Summit X LLC reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
  • Summit X LLC sold 197 iShares Biotechnology ETF shares in Q4 2020, an estimated $542.
  • Summit X LLC first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 7 quarters.
  • Summit X LLC's iShares Biotechnology ETF position peaked at $3.08M in Q3 2017.
  • 856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Summit X LLC's 13F filing for Q4 2020, filed 29 Jan 2021.